NCT03259230View on ClinicalTrials.gov

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

October 13, 2016

Primary Completion Date

January 29, 2020

Study Completion Date

January 29, 2020

Conditions
Hemophagocytic Lymphohistiocytosis
Interventions
OTHER

Blood Draws

OTHER

Data Collection

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

lead

Swedish Orphan Biovitrum

INDUSTRY